A comparison of short-term therapeutic efficacy between infliximab and tacrolimus for moderate to severe ulcerative colitis
Introduction. Both infliximab (IFX) and tacrolimus (Tac) are effective for inducing clinical remission in patients with ulcerative colitis (UC). However, no randomized study has addressed the relative efficacies of IFX and Tac for patients with moderate to severe UC. This study aimed to conduct a re...
Main Authors: | Yamagami Hirokazu, Nishida Yu, Nagami Yasuaki, Hosomi Shuhei, Yukawa Tomomi, Otani Koji, Tanaka Fumio, Taira Koichi, Kamata Noriko, Tanigawa Tetsuya, Shiba Masatsugu, Watanabe Toshio, Fujiwara Yasuhiro |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2017-09-01
|
Series: | Romanian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/rjim-2017-0012 |
Similar Items
-
Experience with long-term infliximab therapy in patients with ankylosing spondylitis
by: Oksana Alekseevna Rumyantseva, et al.
Published: (2010-12-01) -
Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis
by: Gabriela Maria Henz Giovelli, et al.
Published: (2023-12-01) -
Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis
by: Lin W, et al.
Published: (2019-07-01) -
A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's disease
by: Ziheng Peng, et al.
Published: (2023-12-01) -
Risk factors of new-onset glucose abnormalities in idiopathic membranous nephropathy patients on glucocorticoid plus tacrolimus
by: Jin Li, et al.
Published: (2023-11-01)